Neovasc Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Vancouver and minneapolis, july 26, 2022 (globe newswire) -- via newmediawire – neovasc, inc. ("neovasc" or the "company") (nasdaq, tsx: nvcn) today announced the united states food and drug administration (“fda”) has approved a protocol supplement to the cosira-ii investigational device exemption (“ide”) trial. the approval expands the number of patients eligible for treatment in the trial and adds two previously planned imaging sub-studies designed to provide insights into the safety and mechanism of action of the neovasc reducer™ (“reducer”). the timing of the approval is ahead of the company's internal target and will allow for additional patients to be treated.

Expansion driven by nice guidelines and enhanced reimbursement for the neovasc reducer™

Vancouver, british columbia and minneapolis, minnesota--(newsfile corp. - may 16, 2022) - neovasc inc. (nasdaq: nvcn) (tsx: nvcn) ("neovasc" or the "company") announced today that it has received written notification from the nasdaq stock market llc (the "nasdaq") informing the company that it has regained compliance with the minimum bid price requirement under nasdaq listing rule 5550(a)(2) pursuant to nasdaq listing rule 5810 for continued listing on the nasdaq.as previously reported, on may 24, 2021,...

Report demonstrates objective improvements in patients suffering from microvascular dysfunction

Vancouver, bc, april 27, 2022 (globe newswire) -- via  newmediawire -- neovasc inc. ("neovasc" or the "company") (nasdaq: nvcn)(tsx: nvcn), a leader in the development of minimally invasive devices for the treatment of refractory angina, and in the development of minimally invasive transcatheter mitral valve replacement technologies, announced today that the company has filed articles of amendment, effective today, to effect the previously announced share consolidation (reverse stock split) (the “consolidation”) of its issued and outstanding common shares (the “common shares”) on the basis of one (1) post-consolidation common share for every twenty-five (25) pre-consolidation common shares...

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 8, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced that its management team will be participating in the 2022 Sidoti & Co. Summer Small Cap Virtual Investor Conference to be held June 15-16, 2022. Neovasc's Chief Operating Officer, Bill Little, will be presenting at 1:45 pm ET on Wednesday, June 15.The presentation can be accessed here. Additionally, a recording of the...

VANCOUVER and MINNEAPOLIS, May 23, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire --  Neovasc, Inc.  (Neovasc or the Company) ( NASDAQ  ,  TSX  : NVCN) today announced that its management team will be participating in the H.C. Wainwright Global Investment Conference to be held May 23-26, 2022. Fred Colen, Neovasc's President and Chief Executive Officer, will be presenting at 11:00 am ET on Wednesday, May 25.

Neovasc Inc. (NASDAQ:NVCN ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Fred Colen - President and Chief Executive Officer Chris Clark - Chief Financial Officer Conference Call Participants Vernon Bernardino - H.C. Wainwright Operator Greetings and welcome to Neovasc First Quarter 2022 Earnings Conference Call.

Neovasc (NVCN) delivered earnings and revenue surprises of -140.80% and 23.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 29, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the quarter ended March 31, 2022 on Thursday, May 12, 2022. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, Chief Financial Officer, will host a conference call to review the company's results at 4:30 pm EDT on May 12, 2022.Interested parties may access the conference call by dialing (877) 407-9208...

Neovasc Inc.'s (NVCN) CEO Fred Colen on Q4 2021 Results - Earnings Call Transcript

Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) -  Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the quarter and full year ended December 31, 2021 on Thursday, March 10, 2022. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, Chief Financial Officer, will host a conference call to review the company's results at 4:30 pm EDT on March 10, 2022.Interested parties may access the conference call by dialing (877) 407-9208...

VANCOUVER and MINNEAPOLIS, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ,TSX: NVCN) today announced that its management team will be participating in the 2022 H.C. Wainwright BIOCONNECT Virtual Conference to be held January 10-13, 2022.  A recorded presentation by Fred Colen, Neovasc's Chief Executive Officer, will be available on the conference website starting at 7:00 am EST on Monday, January 10.  The recording will be archived for 90 days.

Neovasc Inc. (NVCN) CEO Fred Colen on Q3 2021 Results - Earnings Call Transcript

VANCOUVER, Nov. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire –  Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the quarter ended September 30, 2021 on Tuesday, November 9, 2021. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, Chief Financial Officer, will host a conference call to review the company's results at 4:30 pm EDT on November 9, 2021.